RESEARCH TRIANGLE PARK, N.C.-(BUSINESS WIRE)-Quintiles Transnational Corp., the world’s largest pharmaceutical services company, has been named to TRAINING magazine’s “Training Top 125,” the publication’s annual report that ranks companies based on their employer-sponsored training and development programs.
Quintiles enters the Training Top 125 for the first time at number 80, and is the only major contract research organization (CRO) in the 2009 rankings. This year’s Top 125 is a diverse cross-section of global industry leaders including companies ranging from Microsoft, Intel and Wells Fargo to Wyeth Pharmaceuticals, McDonalds and General Mills.
While Quintiles has frequently been cited by both customers and competitors as one of the best providers of training in the industry, inclusion in the Training Top 125 is an honor that speaks to the important role of Quintiles’ Global Learning & Development function.
“We are delighted to have Quintiles’ training and development recognized with our inclusion in the Training Top 125,” said Tim Bray, Quintiles Vice President, Global Learning and Development. “The growth and development of our people is critical to our success because our customers expect consistent service delivery on a global basis.
“Quintiles is able to meet this demand through established processes which are delivered by highly competent personnel the first time, every time,” Bray continued. “We believe our investment in learning and development plays a key role in making this a reality.”
Selection of the Training Top 125 is based on a variety of benchmarking statistics such as total training budget; percentage of payroll; number of training hours per employee program; goals, evaluation, measurement, and workplace surveys; hours of training per employee annually; and detailed formal programs.
Ranking within each year’s Top 125 is determined by assessing a range of qualitative and quantitative factors, including financial investment in employee development, the scope of development programs, and how closely such development efforts are linked to business goals and objectives. Other factors include Human Resources data such as turnover and new employee referrals.
About Training Magazine
Training magazine is the leading business publication for learning and development and HR professionals. It has been the ultimate resource for innovative learning and development--in print, in person, and online-over the last 30 years. Training magazine and Training magazine Events are produced by Nielsen Business Media, a part of The Nielsen Company, a global information and media company. For information, please visit, www.nielsen.com.
About Quintiles
Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, strategic partnering and commercialization for the pharmaceutical, biotechnology and medical device industries. With more than 22,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company’s Web site at www.quintiles.com.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.